Katalog CVE
CVSS 9.8 · Critical
KEV · sudah dieksploitasi
EPSS 14,9%
Kerentanan Unrestricted Upload of File with Dangerous Type pada balbooa forms. Skor CVSS 3.1 9.8 (Critical) menurut NVD. Masuk katalog KEV CISA pada 10 Juli 2026, artinya sudah terbukti dieksploitasi.
Deskripsi (NVD)
Joomla Extension - balbooa.com - Unauthenticated file upload in Balbooa Forms extension < 2.4.1 - The Joomla extension Balbooa Forms is vulnerable to an unauthenticated arbitrary file upload that allows uploading executable files and leads to full RCE.
Rincian
- Terbit di NVD
- 9 Juli 2026
- Terakhir diubah
- 24 Juli 2026
- Status NVD
- Analyzed
- CVSS 3.1
- 9.8 (Critical), sumber NVD
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
· uraikan di kalkulator
- Jenis kelemahan (CWE)
-
CWE-434: Unrestricted Upload of File with Dangerous Type
- EPSS (30 hari)
- 14,9% peluang dieksploitasi; lebih tinggi dari 96,6% CVE lain
Known Exploited Vulnerabilities (CISA)
- Nama
- Balbooa Forms Unrestricted Upload of File with Dangerous Type Vulnerability
- Masuk KEV
- 10 Juli 2026
- Tenggat CISA
- 13 Juli 2026 (untuk instansi federal AS)
- Ransomware
- Belum tercatat
- Tindakan wajib
- Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.
Produk dan versi terdampak
| Vendor | Produk | Versi terdampak |
| balbooa |
forms |
Semua versi sebelum 2.4.1 |
> Data dari konfigurasi CPE di NVD.
Referensi dan perbaikan
Sumber:
NVD ·
CVE.org
·
KEV CISA
·
EPSS.
Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA.
Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat
kanal pelaporan.